Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
Severa M, Rizzo F, Sinigaglia A, Ricci D, Etna MP, Cola G, Landi D, Buscarinu MC, Valdarchi C, Ristori G, Riccetti S, Piubelli C, Palmerini P, Rosato A, Gobbi F, Balducci S, Marfia GA, Salvetti M, Barzon L, Coccia EM. Severa M, et al. Among authors: palmerini p. Clin Transl Immunology. 2023 Mar 23;12(3):e1434. doi: 10.1002/cti2.1434. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36969367 Free PMC article.
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma.
Viragova S, Aparicio L, Palmerini P, Zhao J, Valencia Salazar LE, Schurer A, Dhuri A, Sahoo D, Moskaluk CA, Rabadan R, Dalerba P. Viragova S, et al. Among authors: palmerini p. J Natl Cancer Inst. 2023 Jul 6;115(7):838-852. doi: 10.1093/jnci/djad062. J Natl Cancer Inst. 2023. PMID: 37040084 Free PMC article.
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.
Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, Chieregato K, Mozzo V, Perbellini O, Tisi MC, Trentin L, Visco C, Ruggeri M, Sommaggio R, Rosato A. Dalla Pietà A, et al. Among authors: palmerini p. J Immunother Cancer. 2021 Jul;9(7):e002475. doi: 10.1136/jitc-2021-002475. J Immunother Cancer. 2021. PMID: 34272306 Free PMC article.